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Background: Gastroesophageal reflux disease (GERD) is associated with impaired epithelial barrier function that is
regulated by cell-cell contacts. The aim of the study was to investigate the expression pattern of selected
components involved in the formation of tight junctions in relation to GERD.
Methods: Eighty-four patients with GERD-related symptoms with endoscopic signs (erosive: n = 47) or without
them (non-erosive: n = 37) as well as 26 patients lacking GERD-specific symptoms as controls were included.
Endoscopic and histological characterization of esophagitis was performed according to the Los Angeles and
adapted Ismeil-Beigi criteria, respectively. Mucosal biopsies from distal esophagus were taken for analysis by
histopathology, immunohistochemistry and quantitative reverse-transcription polymerase chain reaction (RT-PCR)
of five genes encoding tight junction components [Occludin, Claudin-1, -2, Zona occludens (ZO-1, -2)].
Results: Histopathology confirmed GERD-specific alterations as dilated intercellular spaces in the esophageal
mucosa of patients with GERD compared to controls (P < 0.05). Claudin-1 and −2 were 2- to 6-fold upregulation
on transcript (P < 0.01) and in part on protein level (P < 0.015) in GERD, while subgroup analysis of revealed this
upregulation for ERD only. In both erosive and non-erosive reflux disease, expression levels of Occludin and
ZO-1,-2 were not significantly affected. Notably, the induced expression of both claudins did not correlate with
histopathological parameters (basal cell hyperplasia, dilated intercellular spaces) in patients with GERD.
Conclusions: Taken together, the missing correlation between the expression of tight junction-related components
and histomorphological GERD-specific alterations does not support a major role of the five proteins studied in the
pathogenesis of GERD.
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Gastroesophageal reflux disease (GERD) is one of the
most prevalent gastrointestinal disorders in the world
[1,2]. Based on endoscopic findings GERD is differen-
tiated in erosive (erosive reflux disease or ERD), non-
erosive reflux disease (NERD) and Barrett’s esophagus
(BE) [3,4]. ERD is characterized by endoscopic visible
breaks of esophageal mucosa integrity and classified
according to various endoscopic classifications, most
recently the Los Angeles classification [5,6]. However,* Correspondence: thomas.wex@med.ovgu.de
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distribution, and reproduction in any mediumtwo thirds of patients with typical GERD symptoms do
not exhibit visible mucosal changes in conventional eso-
phagogastroduodenoscopy (EGD) and are thus diag-
nosed as having NERD [6,7]. Although histology is not
used in clinical practice for GERD diagnosis, frequent
histological changes as basal cell hyperplasia, elongation
of the papilla, inflammatory infiltrates and dilatation
of the intercellular spaces are observed in the distal
esophagus of patients with both ERD and NERD [8-11].
Dilations of the intercellular spaces (ICS) are character-
istic changes of the esophageal mucosa of patients with
ERD and NERD. ICS were described by various others
using electron microscopy and are even characterized
by light microscopy. This feature is being more widely
proposed as an additional morphological feature of acid-entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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The widened ICS are supposed to permit the diffusion
of molecules to the lamina propria where sensory nerve
endings are located [15]. Therefore, ICS dilation even in
the absence of endoscopically visible mucosal damage
may explain the occurrence of symptoms in patients
with NERD [16,17]. Furthermore, recent studies have
provided evidence that the impaired barrier function of
esophageal mucosa is a “hallmark” of GERD [18-20].
The integrity of epithelial surfaces is based on various
cell-cell contacts that provide the structural basis for
barrier function by regulating the diffusion of molecules
and sorting of transmembrane proteins to apical and
basolateral surfaces. Tight junctions, adherens junction
and desmosomes are the three major structural units
mediating barrier and sorting function [21,22]. Their
structural composition, general functions, and patho-
physiological relevance have been reviewed extensively
by others [21,23,24]. In line with the current concept in
GERD, the role of molecules contributing to cell-cell
contacts in esophageal mucosa in relation to GERD has
been investigated in animal and human studies recently.
Notably, the majority of studies were focused on the role
of tight junction molecules (e.g. Claudin-2, -3, -4, -7 and
−18) in Barrett’s metaplasia and carcinogenesis towards
esophageal adenocarcinoma [25-30]. In regard to the
other 2 endoscopic entities (ERD, NERD), distinct altera-
tions in the expression and or localization were
described for Claudins 3 and 4 in GERD-related animal
and in vitro models [31-33]. Rat model revealed
decreased expression of Claudin-3 and no change of
Claudin-1 and 4 [31,32], while an in vitro model of
esophageal-like squamous cells demonstrated a promin-
ent role of Claudin-4 [33].
Here, we studied the expression patterns of five tight-
junction related molecules (Occludin, Claudin-1, -2 and
Zonula occludens-1-, 2) in the esophageal mucosa of a
prospective cohort of patients with GERD as well as
reflux-negative individuals. Gene expression was assessed
both on transcriptional and protein level, and changes
were studied in context to histopathological alterations
associated with GERD.
Methods
Study design and patients’ characteristics
Between 2005 and 2007, a cohort of patients with GERD
and individuals lacking any symptom or endoscopic sign
of GERD as GERD-negative controls were enrolled [34].
Patients with typical GERD-related symptoms based on
Montreal classification [4] and patients without any
reflux-related clinical symptoms undergoing EGD for
screening or non-reflux dyspepsia (GERD-negative con-
trols with a reflux disease questionnaire, RDQ score of
0) were invited to participate. All the patients underwenta detailed history and physical examination. The demo-
graphic data and endoscopic findings of the study popu-
lation are presented in Table 1A and Table 1B. Written
informed consent was obtained from all patients before
endoscopy, after the endoscopist had explained the
procedure to the patient in detail and answered all ques-
tions. The study was approved by the ethical committee
of our institution and conducted according to the ethical
guidelines of the declaration of Helsinki as revised
in 1989.
Functional investigations such as 24 hour-pH-metry
or MII-pH analysis were performed in individual
cases only, and could not be included as separate param-
eter. The assignment of NERD was additionally based
on the responsiveness to PPI therapy that was subse-
quently assessed.
Inclusion criteria
Female or male, age 18 to 80, able to provide written
informed consent. Patients with typical reflux symptoms
had to present symptoms at least three times a week.
Typical reflux symptoms were defined as heartburn and
regurgitation, as evaluated by the RDQ score. Patients
with other types of reflux symptoms were not included
in this study.
Exclusion criteria
Upper gastrointestinal pathology (e.g. peptic ulcers,
cancers, polyps, and Barrett’s mucosa), systemic inflam-
matory, neoplastic or malabsorptive diseases (e.g.
Crohn’s disease, ulcerative colitis, vasculitis, celiac dis-
ease), and acute medical conditions such as pneumonia,
stroke, coronary ischemia and acute renal failure.
Patients with known abnormal coagulation parameters
and thrombocytopenia at the time of the procedure (i.e.
INR > 1.2, platelet count < 80,000) were also excluded.
None of the patients had taken antibiotics, or bismuth
compounds or any H2-blockers or proton-pump inhibi-
tors (PPI) in the last 2 weeks before entering the study.
It is notable that the majority of patients enrolled had
various anti-secretory medications in their past, and
does not present GERD-naïve patients. Each patient was
assigned a coded number. Histopathological assessment
was done by pathologist (DK) blinded to clinical data.
Endoscopy and histopathology
The patients underwent the procedure after an overnight
fast. The endoscopy was performed under conscious
sedation with intravenous midazolam using a video-
gastroscope (Q160, Olympus, Hamburg). Endoscopic
characterization of esophagitis was performed according
to the “Los Angeles classification” [35] describing the
following endoscopic landmarks: gastroesophageal junc-
tion (GEJ), Z-line, beginning of the gastric folds and
Table 1 Patient groups analyzed by quantitative RT-PCR and immunohistochemistry
Quantitative RT-PCR Controls (n = 26) NERD (n = 37) ERD (n = 47)
Sex (male/female) 6/20 6/31 31/16#
Age (mean, sd, range) 52.3 ± 17.6 47.0 ± 14.1 47.5 ± 15.4
(20–79) (18–72) (20–79)
H. pylori-status (positive) 5/21 7/30 12/35
(23.1 %) (22 %) (29.2 %)
Immunohistochemistry Controls (n = 12) NERD (n = 13) ERD (n = 16)
Sex (male/female) 2/10 4/9 10/6#
Age (mean, sd, range) 46.2 ± 19.1 48.9 ± 9.5 48.6 ± 14.1
(20–75) (35–64) (29–72)
H. pylori-status (positive) 4/8 2/11 7/9
(33.3 %) (15.4 %) (43.8 %)
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ning of the gastric folds, whereas the Z-line was defined
as the squamocolumnar junction. The cardia was
defined as the mucosa lying immediately below the GEJ.
In the distal esophagus, 3 biopsies were taken 2 cm
above the squamous-columnar junction at the 3 o'clock
position. In case of erosions, specimens were taken 2 cm
above the tip of the erosion. One biopsy was snap-frozen
in liquid nitrogen for molecular analysis. The two other
biopsies were immediately fixed in 4 % neutral-buffered
formalin and submitted for histopathological examina-
tions using hematoxilin and eosin, modified Giemsa and
PAS stain. In analogy to the Sydney classification for
gastritis, the density of intraepithelial neutrophils/eosi-
nophils and lymphocytes were scored to evaluation ac-
tive and chronic inflammation. Furthermore, degree of
basal cell hyperplasia, presence of papillary elongation
and dilated intercellular spaces were semiquantitatively
scored as either 0 (absent), 1 (mild), 2 (moderate), or 3
(severe) as described previously [34]. Notably, several
subgroups of the study cohort were published in regard
to inflammatory mediators (e.g. cytokines, Protease-
activated receptor 2) [34,36], molecules related to barrier
functions [37,38], desmosomal proteins [39] and histo-
pathological alterations [34].
Extraction of RNA and quantitative reverse
transcription - polymerase chain reaction (RT-PCR)
analysis of tight junction-related genes
Extraction of total RNA and cDNA synthesis were per-
formed by the “two-step” protocol as described previ-
ously [40]. Transcript levels of Occludin, Claudin-1, -2,
Zonula occludens-1, -2, and β-Actin were determined by
quantitative real-time RT-PCR using an iCycler (BioRad,
Munich, Germany) and the QuantiTect™ SYBR Green
kit (Qiagen) using primers and standard conditions
described in Table 2. Initial template mRNA amounts
for all genes were calculated using iCycler software (Ct-values) and serial dilutions of plasmid DNA standard
containing the corresponding PCR-fragments. Calculat-
ing template concentrations based on the Ct method
and standard dilutions allowed an individual assessment
of different efficiency for each PCR assay that were be-
tween 0.95 and 0.99. Gene-specific levels were normal-
ized to the corresponding ß-actin level of the sample.
Final results are expressed as arbitrary units (a.u.) and
represent ratios between investigated gene and ß-Actin
transcript amounts. All together, gene expression levels
are identical to those calculated by the 2-ΔΔ Ct-method
[41], but they are additionally adjusted to the assay-
specific efficiency. Due to the primer design (usage of
intron-spanning regions), amplification of genomic DNA
was excluded. All amplification products were checked
for their correct size by agarose gel electrophoresis.
Therefore, gene expression levels (a.u.) illustrate the
mRNA pool of the individual gene studied.
Immunohistochemical analysis of tight junctional
components
Immunohistochemistry was performed using the avidin-
biotin complex immunostaining method and the auto-
mated immunohistochemistry slide staining system by
Ventana NexES (Ventana Medical System, Strasbourg,
France) as described previously [36]. Details for antigen
retrieval and primary antibodies are illustrated in Table 2.
Dilutions of primary antibodies were determined using
appropriate positive and negative controls. For negative
controls, primary antibody was replaced by irrelevant
rabbit IgG that did not reveal specific signals (data not
shown). Immunoreactivity was assessed in 5 representa-
tive high power fields (Zeiss Axioskop 50) of each sample
by one blinded pathologist (DK). For semiquantitative
assessment an adaptation of a score system originally
described by Remmele et al. was applied [42]. Briefly,
staining intensity ([SI], 1 = weak, 2 =moderate, 3 = strong)
and the percentage of positive cells ([PPC], 1 = <10%,
Table 2 Characteristics of primers, RT-PCR protocol and antibodies
Primer sequence, length of fragment,
annealing temperature
Antibody, Company, Antigen retrieval, final dilution
Occludin fw: GGCCATTGCCATTGTACTGGG
rv: GGAACCGGCGTGGATTTATAGG315 bp; 58°C
polyclonal rabbit anti-occludin antibody No. 71–1500 (Invitrogen,
Carlsbad, CA, USA), Protease-retrieval, Final dilution: 1:50
Claudin-1 fw: ATGGTGGTTGGCATCCTCCTG
rv: GGCCTTGGTGTTGGGTAAGAGG344 bp, 58°C
polyclonal rabbit anti-Claudin-1 antibody No. 51–9000, clone JAY.8
(Invitrogen, Carlsbad, CA, USA), EDTA-retrieval, Final dilution: 1:50
Claudin-2 fw: TCTCTTGGCCTCCAACTTGTGGG
rv: GCACTGGATGTCACCATCATGGC259 bp, 60°C
polyclonal rabbit anti-Claudin-2 antibody No. 51–6100 (Invitrogen,
Carlsbad, CA, USA), EDTA-retrieval, Final dilution: 1:50
ZO-1 fw: TCTGATCATTCCAGGCACTCGC
rv: CCACATCTGGTTGCCAACTTGG225 bp, 58°C
polyclonal rabbit anti-ZO-1 antibody No. 61–7300, (Invitrogen,
Carlsbad, CA, USA, Protease retrieval, Final dilution: 1:30
ZO-2 fw: AGAGGACACGCCGAGCAGATTG
rv: TCCCGACATCATTGCCACCAG272 bp, 60°C
polyclonal rabbit anti-ZO-2 antibody No. 71–1400, (Invitrogen,
Carlsbad, CA, USA, EDTA retrieval, Final dilution: 1:150
β-Actin fw: CATGCCATCCTGCGTCTGGACC
rv: ACATGGTGGTGCCGCCAGACAG400 bp, 60°C
not performed
Standard protocol 95°C: 15 min; (94°C: 30s, 58°-60°C: 30s,
72°C: 30s) 40 cycles; 72°C: 5 min
mab: monoclonal antibody, fw: forward, rv: reverse.
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quantitatively, resulting in an immunoreactive score
[IRS = SI x PC] between 0 and 12. Furthermore, a score
for membranous staining (0 = none, 1 = weak, 2 =moder-
ate, 3 = strong/complete) was added resulting in a pos-
sible maximum of 15 points for each sample.
Statistical analysis
Data are expressed as absolute number, relative propor-
tion, median + range or mean ± standard deviation (SD)
if not stated otherwise. Since the majority of data sets
revealed skewed distribution, non-parametric Kruskal-
Wallis test were applied for all comparisons made
among the three groups (controls, NERD and ERD). If
significant differences were identified (P < 0.05), post hoc
analyses for pairwise comparisons between groups were
performed using Mann–Whitney U test for gene expres-
sion analysis and immunohistochemistry. Age and histo-
pathological parameters were analyzed by ANOVA and
T test; frequencies by chi-square test. Non-parametric
correlation analysis was performed by Spearman’s
rank correlation test to investigate potential association
between gene expression levels and histomorphological
changes. Correlation analyses were performed in explo-
rative manner only; adjustment for multiple comparisons
was not performed. All tests were applied two-sided with
a level of significance of P < 0.05.
Results
Patients and GERD-specific histomorphological changes
The three groups as well as the subgroups (randomly
selected for immunohistochemistry) did not differ with
respect to age and H. pylori status (Table 1). Histomor-
phological alterations are shown in Table 3. Activity and
chronicity scores in esophageal mucosa were slightly
higher in patients with NERD or ERD vs. controlswithout reaching significance. Basal cell hyperplasia,
dilated intercellular spaces and elongation of papilla
were significantly increased in both endoscopic entities
(Table 3).
Upregulation of tight junction-related proteins in
esophageal mucosa in context to the presence of
gastroesophageal reflux disease
As exemplarily demonstrated in figure 1, Claudin-1 tran-
script and protein levels in esophageal mucosa were
significantly increased in patients with ERD, while a
weaker increase was noted in NERD compared to
controls. Corresponding data for the other four genes
(Claudin-2, ZO-1, ZO-2; Occludin) including those of
Claudin-1 are summarized in tables 4A and 4B.
Claudin-2 had a similar expression pattern as Claudin-1,
and both ZO-1 and ZO-2 showed a tendency to higher
transcript levels in ERD and NERD (P-values <0.07,
Table 4A). In addition to the upregulation in context
to controls, both transcript levels and immunohisto-
chemical scores of Claudin-1 were significantly higher
in patients with ERD compared to those with NERD
(Figure 1).
In general, higher transcript levels were accompanied
by higher immunohistochemical scores for most pro-
teins. In addition to these quantitative changes in gene
expression, different patterns of protein distribution
within the cell compartment and within different muco-
sal layers were noted (Figure 2). In controls, the expres-
sion of tight junction-related proteins was mainly
observed in the basal epithelial layers and in a cytoplas-
matic pattern. In GERD, expansion of protein expression
to the suprabasal und spinous epithelial layers was
observed. Furthermore, expression of Claudin-1, Claudin-
2 and ZO-1 was partly membrane-associated with a
stronger intensity in GERD compared to controls.
Table 3 Histopathological parameters
Controls NERD ERD P-value One way
ANOVA
Activity 0 ± 0 0.23 ± 0.54 0.22 ± 0.41 n.s.
Chronicity 0.72 ± 0.54 0.97 ± 0.51 1.05 ± 0.67 n.s.
Basal cell hyperplasia [BSH] 0.52 ± 0.59 1.11 ± 0.63 1.42 ± 0.84 <0.001
Papillary elongation [PE] 1.32 ± 0.80 1.71 ± 0.86 2.07 ± 0.85 <0.001
Dilated intercellular spaces [ICS] 0.72 ± 0.68 1.49 ± 1.01 2.10 ± 0.13 <0.001
Parameters were scored semiquantitatively as described in “Patients and Methods”. Data are presented as mean ± sd.
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molecules (transcript level) does not correlate with
histomorphological changes in esophageal mucosa
In order to study potential correlations between gene
expression levels (transcript level) and the degree of
histopathological alterations, all three groups were ana-
lyzed together in the first step. As exemplarily illustrated
in figure 3, gene expression levels of Claudin-1 and
Claudin-2 marginally correlated with the degree of basal
cell hyperplasia, but not with dilated intercellular spaces
and length of papilla (data not shown). Since most ana-
lyses were negative, these data are summarized in
Table 5A for all five genes. Since basal cell hyperplasia
revealed some even weak correlations in the complete
study cohort, these correlation analyses were performed
again for all three groups individually and for patients
with GERD (NERD + ERD) combined. Only 3 out of 20
subanalyses revealed marginally significant correlations
(without adjustment for multiple comparisons), two of
those were identified in controls (data summarized in
Table 5B).
In addition to the correlation based on transcript
levels (Figure 3, Table 5), correlation analysis between
protein expression levels (immunohistochemical scores,
Table 4B) and histopathological alterations (Table 3) was
performed. Here, only one significant correlation (be-
tween Claudin-1 and activity of inflammation, r = 0.51,
P < 0.01) was identified (data not shown).
Discussion
In this study, we demonstrated (I) distinct expression
patterns of five genes encoding for proteins involved in
the formation of tight junctions in esophageal mucosa.
In particular Claudin-1 in ERD and to lesser extent
Claudin-2 was expressed at higher levels in patients with
GERD. In contrast, ZO-1, ZO-2, and Occludin were not
affected by the presence of GERD. (II) In general, altered
gene expression of Claudin-1/-2 did not correlate with
the degree of histomorphological changes in the esopha-
geal mucosa of patients with GERD.
Tight junctions are composed of transmembrane pro-
teins such as Occludin, 24 Claudins, several junctional
adhesion molecules (JAMs) with different isoforms, E-Cadherin as well as cytosolic binding partners [43,44].
The selection of the five genes studied was based on
functional aspects. Occludin is critical for the formation
of tight junctions in most tissues [45]. Claudin-1 is one
of the numerous Claudins that seals intercellular space
leading to higher barrier function [46], while Claudin-2
is the only pore-forming member of this family resulting
in increased permeability [47]. Zonula occludens (ZO)-1
and-2 are cytosolic partners of tight junctions in most
epithelial surfaces [48,49]. The selected genes present
important components of the tight junctional complex,
and were considered to allow assessment about altera-
tions of tight junctions in relation to GERD. A compre-
hensive analysis concerning the general expression
pattern of other junctional proteins was not performed.
Recently, several studies demonstrated characteristic
histopathological alterations in esophageal mucosa of
patients with GERD and a proinflammatory response in-
cluding the activation of related pathways such as NFκB,
PAR-2, ROS and iNOS [50,51]. Several in vitro and ani-
mal studies have provided evidence that incubation of
esophageal mucosa or squamous cell lines either with
acidified media with/without bile acids or proinflamma-
tory cytokines can provoke changes in transepithelial
electric resistance and increased transepithelial perme-
ability [52-55]. Notably, several studies demonstrated a
cytokine-mediated change of tight junction-related
molecules in various cell models. For instance, IL-6
markedly induces Claudin-2 expression via MEK and
PI3K signaling leading to increased tight junction per-
meability [56]. In a rabbit model of GERD, elevated IL-6
expression correlated with induction of several tight
junction-related proteins (Claudin-1, Occludin, JAM-1,
ZO-1) [57] and altered the motogenic activity of smooth
muscle cells [58].
All together, there is sufficient data showing that the
exposure of mixed gastric or gastroduodenal refluxate
causes altered esophageal epithelial barrier function,
inflammation and cellular damage, although the timely
order of these processes is a matter of debate [20]. As
today, it is well accepted that impaired epithelial barrier
function of the distal esophagus presents a major patho-
physiological process in GERD.
Figure 1 Expression of Claudin-1 in the esophageal mucosa of
patients with NERD and ERD. The upper panel presents data of
RT-PCR analysis; the lower panel illustrates immunohistochemical
scores. Data are shown as boxplots illustrating 25, 75 percentile,
median and 5–95 range. Note that due to skewed data distribution
Claudin-1 (ERD) is presented as line only. Significant differences
compared to controls are marked by a star (#); further details are
presented in Tables 4A, and B.
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related proteins in relation to ERD and NERD in muco-
sal samples. In particular, Claudin-1 and Claudin-2,
though mediating opposite functionally effects, were
induced, while cytoplasmic adapters and Occludin were
rather unchanged in relation to controls. The higherexpression of Claudin-1 (both on transcript and protein
level) was the only significant difference identified
between patients with ERD and NERD. The fact that all
other identified changes were similar between NERD and
ERD supports the concept of similar pathophysiological
mechanisms between both diseases. Unexpectedly, these
changes did not correlate with histomorphological alter-
ations, in particular with dilated ICS in esophageal
mucosa. This finding is in contrast to the recently identi-
fied correlation between histopathological alterations,
in particular basal cell hyperplasia, and elevated gene
expression of desmosomal proteins [39]. In this study,
few borderline correlations were found for basal cell
hyperplasia and some genes only, but notably these find-
ings were mostly restricted to reflux-negative controls,
whereas patients with GERD did not reveal significant
correlations between histopathological alterations and
transcript levels of the five genes. Since correlation ana-
lyses were performed in an explorative way (without
adjustment for multiple comparison), the few significant
correlations (with borderline significance) do not support
a general role of these findings for the pathophysiology
of GERD. Taken into consideration this limitation and
the fact that that the overall majority of our comparisons
(17 out of 20) revealed no correlations, we conclude that
our data do not give evidence for an association between
the gene expression of the five genes studied and the
histopathological changes in our study groups. It is well
known that extent of basal cell hyperplasia reflects pro-
liferative status of esophageal mucosa [9]. Since the iden-
tified correlations between gene expression levels and
basal cell hyperplasia were mostly restricted to controls,
it is unlikely that elevated Claudin-1 levels in ERD reflect
tissue repair in context to mucosal damage caused by
refluxate in these patients. Since we and others demon-
strated more severe histomorphological alterations in
ERD than NERD, the overall consistent changes of the
5 genes and their corresponding proteins in both dis-
eases seem to be of limited relevance to the mucosal
integrity and function. Furthermore, it is notable that
some of the stainings revealed not the typical membrane-
restricted expression pattern as demonstrated for these
tight junction-related molecules im most gastrointestinal
tissues [59,60]. However, cytoplasmic or diffuse mem-
branous expression patterns have been identified for
Claudin-2 [60] and ZO-1 [61] in human gastrointestinal
tissue and for Claudin-1 in esophageal mucosa of rat [62].
Occludin staining pattern or expression in esophageal
mucosa differs frequently also from those identified
in gastric or intestinal mucosa [60,63]. Overall, the
subcellular distribution of the 5 tight junction-related
proteins seems to differ partially from those identified
in columnar-lined epithelium. However, the study was
Table 4 Expression of tight junction-related components in esophageal mucosa in patients with GERD





posthoc: Man Whitney U test)
Occludin 0.098*
controls 0.041 (0.0086 - 0.38)
NERD 0.060 (0.0052 - 0.57) 1.46 n.a.
ERD 0.035 (0.0026 - 1.09) 0.85 n.a.
Claudin-1 0.0097*
controls 0.078 (0.0072 - 2.54)
NERD 0.15 (0.012 - 1.6) 1.92 0.016
ERD 0.20 (0–4.1) 2.56 0.0032
Claudin-2 0.0027*
controls 0.000038 (0–0.003)
NERD 0.0002 (0–0.019) 5.26 0.0041
ERD 0.000083 (0–0.021) 2.18 0.11
ZO-1 0.069*
controls 0.0060 (0.0012 - 0.073)
NERD 0.0081 (0–0.067) 1.35 n.a.
ERD 0.0077 (0.0015 - 0.21) 1.28 n.a.
ZO-2 0.061*
controls 0.011 (0.0022 - 0.038)
NERD 0.019 (0.002 - 0.27) 1.72 n.a.
ERD 0.021 (0.0019 - 0.59) 1.9 n.a.
Panel BProtein level IHC scoremedian (range) Change (x-fold) vs. controls P-values (* Kruskal-Wallis;
posthoc: Man Whitney U test)
Occludin 0.02*
controls 3 (1 – 9) -
NERD 6 (1 – 15) 2.0 0.026
ERD 8 (1 – 12) 2.7 0.012
Claudin-1 0.014*
controls 1 (1 – 4) -
NERD 2 (1 – 9) 2.0 0.14
ERD 6 (1 – 8) 6.0 0.0004
Claudin-2 0.0057*
controls 4 (1 – 9) -
NERD 6 (1 – 12) 1.5 0.28
ERD 9 (4 –15) 2.25 0.0025
ZO-1 0.62*
controls 2 (0 – 6) -
NERD 4 (1 –12) 2.0 n.a.
ERD 3 (0 – 3) 1.5 n.a.
ZO-2 0.58*
controls 4 (0 – 10) -
NERD 4 (0 – 8) 1.0 n.a.
ERD 1 (0 – 8) 0.25 n.a.
Transcript levels are shown in relation to controls (Panel A). Immunohistochemical scores are illustrated similarly (Panel B). Statistical analyses for both datasets
were done first by non-parametric Kruskal-Wallis (P-value italic style); if significant post-hoc analysis was done by Mann Whitney U test. Significant changes are
demonstrated by bold letters. n.a.: not applicable.
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Figure 2 Immunohistochemical stainings of tight junction-related proteins in esophageal mucosa. Occludin, Claudin-1, -2 and ZO-1,-2
are displayed by brown or red staining, respectively. Panels illustrate representative staining for controls and samples obtained from patients
with NERD. Immunohistochemical staining was observed in the esophageal squamous epithelium mainly at the basal and suprabasal zone.
Claudin-1/2 and ZO-1 showed partly a membranous staining. (Zeiss Axioskop 50; camera: Nikon coolpix 990).
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tern of the molecules in esophageal mucosa on the
subcellular level. The presence of appropriate nega-
tive and positive control stainings in other tissues, andthe good concordance between expression data on
transcript and protein level in general provide further
indirect evidence for the specificity of immunohisto-
chemical stainings.
Figure 3 Correlation of Claudin-1 and Claudin-2 with histomorphological changes in esophageal mucosa. Panels illustrate correlations
between transcript levels and histomorphological alterations as indicated. Data are shown as open dot plots; medians are presented filled dot.
Non-parametric correlation analysis was performed by Spearman’s rank correlation test; P values are presented in figure. Detailed data of other
correlations are presented in Tables 5A, and 5B.
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http://www.biomedcentral.com/1471-230X/12/128Based on the descriptive study design, it remains open
whether the altered gene expression levels of Claudin-1
and −2 contribute to GERD pathophysiology or merely
are markers for the existing disease. Furthermore it is
notable that the majority of patients received GERDTable 5 Correlation between GERD-specific histopathological
junction-related genes (transcript level)
Panel A: All samples Occludin Claudi
Activity n.s. r = 0.23
P = 0.0
Chronicity n.s. n.s.
Basal cell hyperplasia n.s. r = 0.19
P = 0.0
Elongation of papilla n.s. n.s.
Dilated intercellular space n.s. n.s.
Panel B: Basal cell hyperplasia Occludin Claudi
Controls r = 0.47 n.s.
P = 0.02
NERD r = 0.36 n.s.
P = 0.03
ERD n.s. n.s.
GERD (ERD + NERD) n.s. n.s.
Panel A: The histopathological scores (Table 3) were correlated with gene expressio
study cohort (n = 110). Data (r-, and P-values) represent potential correlations betwe
hyperplasia demonstrated significant correlations in global analysis (Panel A), this p
genes with basal cell hyperplasia within each group and for patients with GERD indmedications (PPI, H2RA) in the past before entering
study. Even a stop of at least 2 weeks was mandatory to
enter the study, we can not exclude that the effects of
long-term therapy in the past or the changes induced by
the 2-week stop of medication (e.g. acid rebound) [64]alterations and gene expression level of tight




r = 0.21 r = 0.22 n.s.
5 P = 0.04 P = 0.03
n.s. n.s. n.s.
n.s. n.s. n.s.
n-1 Claudin-2 ZO-1 ZO-2
n.s. r = 0.36 r = 0.42




n levels (transcript levels, Table 4) for each gene individually in the combined
en these parameters (n.s. = not significant). Panel B: Since basal cell
arameter was further analyzed by correlating expression values for all five
ividually as identified in table.
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http://www.biomedcentral.com/1471-230X/12/128could have affect the expression of the five genes stud-
ied. Another limitation is the assessment of protein
expression by an immunohistochemical score that can
be done semiquantitatively at best. Besides this methodo-
logical aspect, posttranscriptional regulatory mechanisms
can lead to different findings between gene expression
analysis performed on transcript and protein levels. But
as mentioned above, overall we observed a good con-
cordance between both levels even not all significant
findings were confirmed by both methodologies. Since
we studied five selected components of tight junction
complexes in GERD only, general conclusions can not
be made. Assessment of other tight junction related
molecules (e.g. Claudins, JAMs, Tricellulin) [44,46,65] in
regard to GERD needs to be performed.
Conclusions
In summary, this study demonstrates a partial upregula-
tion of tight junction-related components, in particular
Claudin-1, in relation to GERD. Since identified molecu-
lar changes do not correlate with histomorphological
alterations in general, a major role of Claudin-1 as of the
other four tight junction-related proteins in the patho-
genesis of GERD can not be concluded from our study.
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